Narlaprevir/Ritonavir and Sofosbuvir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Narlaprevir/Ritonavir and Sofosbuvir, covering 2022-10-31 to 2022-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1 [Phase 2]